Regenxbio Revenue (TTM) Analysis

Regenxbio Inc (RGNX)

11.26 +0.07 (+0.63%) USD | NASDAQ | Nov 08, 10:33

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
September 30, 2024	84.33M
June 30, 2024	89.04M
March 31, 2024	86.73M
December 31, 2023	90.24M
September 30, 2023	99.37M
June 30, 2023	96.97M
March 31, 2023	109.64M
December 31, 2022	112.72M
September 30, 2022	480.03M
June 30, 2022	484.30M
March 31, 2022	473.68M
December 31, 2021	470.35M
September 30, 2021	93.14M
June 30, 2021	161.28M
March 31, 2021	155.81M
December 31, 2020	154.57M
September 30, 2020	144.89M
June 30, 2020	60.68M
March 31, 2020	51.99M

Date	Value
December 31, 2019	35.23M
September 30, 2019	64.24M
June 30, 2019	54.85M
March 31, 2019	87.00M
December 31, 2018	218.50M
September 30, 2018	179.77M
June 30, 2018	175.80M
March 31, 2018	142.33M
December 31, 2017	10.39M
September 30, 2017	10.05M
June 30, 2017	8.838M
March 31, 2017	4.651M
December 31, 2016	4.589M
September 30, 2016	7.341M
June 30, 2016	8.356M
March 31, 2016	7.344M
December 31, 2015	7.595M
September 30, 2015	4.295M
June 30, 2015	3.638M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

35.23M

Minimum

Dec 2019

484.30M

Maximum

Jun 2022

176.75M

Average

104.51M

Median

Revenue (TTM) Benchmarks